An Evaluation of the Safety of Continuing Trastuzumab Despite Overt Left Ventricular Dysfunction

Current Oncology - Canada
doi 10.3747/co.26.4631
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Left Atrial Volume Index (Lavi) in the Evaluation of Left Ventricular Diastolic Dysfunction

Journal of Evolution of Medical and Dental Sciences
2015English

Left Ventricular Systolic Dysfunction

2020English

Detection of Regional Left Ventricular Dysfunction.

BMJ
1971English

The Evaluation of Left Ventricular Function for Patients Being Considered For, or Receiving Trastuzumab (Herceptin) Therapy

British Journal of Cancer
Cancer ResearchOncology
2006English

Markers of Left Ventricular Systolic Dysfunction When Left Ventricular Ejection Fraction Is Normal

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Left Atrial Membrane, Left Ventricular Dysfunction, and Mitral Regurgitation in an Adult

Heart
Cardiovascular MedicineCardiology
2005English

High Incidence of Ventricular Arrhythmias in Patients With Left Ventricular Enlargement and Moderate Left Ventricular Dysfunction

Clinical Cardiology
MedicineCardiovascular MedicineCardiology
2016English

Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Left Ventricular Dysfunction--Bedside Valsalva Manoeuvre.

Heart
Cardiovascular MedicineCardiology
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy